NUVB (Nuvation Bio) FFO


NUVB Nuvation Bio Inc NUVB
33 GF Score
Price $5.65
! 3 Warning Signs
View Full Analysis

What is Nuvation Bio FFO?

FFO (Funds from operations) only applies to REITs.

NUVB
33GF Score
Nuvation Bio Inc NUVB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvation Bio Business Description

Address 1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score

Get the complete analysis for NUVB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.65
Price